Cargando…

Serological response following COVID-19 vaccines in patients living with HIV: a dose–response meta-analysis

To quantify the pooled rate and risk ratio of seroconversion following the uncomplete, complete, or booster dose of COVID-19 vaccines in patients living with HIV. PubMed, Embase and Cochrane library were searched for eligible studies to perform a systematic review and meta-analysis based on PRIMSA g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Qian, Zeng, Furong, Meng, Yu, Liu, Yihuang, Liu, Hong, Deng, Guangtong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279716/ https://www.ncbi.nlm.nih.gov/pubmed/37336939 http://dx.doi.org/10.1038/s41598-023-37051-x

Ejemplares similares

Correlation between CD4 T-Cell Counts and Seroconversion among COVID-19 Vaccinated Patients with HIV: A Meta-Analysis
por: Zhou, Qian, et al.
Publicado: (2023)

Risk and outcomes of breakthrough COVID‐19 infections in vaccinated immunocompromised patients: A meta‐analysis
por: Deng, Guangtong, et al.
Publicado: (2023)

Clinical characteristics, outcomes, and risk factors of SARS-CoV-2 breakthrough infections among 572 fully vaccinated (BBIBP-CorV) hospitalized patients
por: Liu, Yihuang, et al.
Publicado: (2023)

WeChat: a new clinical teaching tool for problem-based learning
por: Zeng, Furong, et al.
Publicado: (2016)

Convalescent plasma for patients with COVID-19
por: Zeng, Furong, et al.
Publicado: (2020)

Commentary on: Nomograms based on inflammatory biomarkers for predicting tumor grade and microvascular invasion in stage I/II hepatocellular carcinoma
por: Xiao, Liang, et al.
Publicado: (2019)

The anti-ferroptotic role of FSP1: current molecular mechanism and therapeutic approach
por: Zeng, Furong, et al.
Publicado: (2022)

Tumor neutrophils ferroptosis: a targetable immunosuppressive mechanism for cancer immunotherapy
por: Du, Songtao, et al.
Publicado: (2023)

Durability of serologic responses to inactivated hepatitis A virus vaccination among people living with HIV following acute hepatitis A outbreak: a 5-year follow-up study
por: Lin, Kuan-Yin, et al.
Publicado: (2023)

A Meta-Analysis of Serological Response Associated with Yellow Fever Vaccination
por: Jean, Kévin, et al.
Publicado: (2016)

Azvudine versus Paxlovid for oral treatment of COVID-19 in Chinese patients with pre-existing comorbidities
por: Dian, Yating, et al.
Publicado: (2023)

Serologic Responses following a Single Dose of SARS-Cov-2 Vaccination in Allogeneic Stem Cell Transplantation Recipients
por: Easdale, Sandra, et al.
Publicado: (2021)

Association of inflammatory markers with the severity of COVID-19: A meta-analysis
por: Zeng, Furong, et al.
Publicado: (2020)

Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis
por: Sakuraba, Atsushi, et al.
Publicado: (2022)

Inhibiting SCD expression by IGF1R during lorlatinib therapy sensitizes melanoma to ferroptosis
por: Zeng, Furong, et al.
Publicado: (2023)

Incidence and Predictors of Serological Treatment Response in Early and Late Syphilis Among People Living With HIV
por: Spagnuolo, Vincenzo, et al.
Publicado: (2018)

Clinical determinants for fatality of 44,672 patients with COVID-19
por: Deng, Guangtong, et al.
Publicado: (2020)

Serological Responses to Influenza Vaccination during Pregnancy
por: Vazquez-Pagan, Ana, et al.
Publicado: (2021)

Serological responses to three doses of SARS-CoV-2 vaccination in inflammatory bowel disease
por: Quan, Joshua, et al.
Publicado: (2023)

Elevated troponin levels predict the reduced efficacy of Paxlovid in COVID-19 patients
por: Zhao, Deze, et al.
Publicado: (2023)

Reduced T-cell response following a third dose of SARS-CoV-2 vaccine in infection-naïve people living with HIV
por: Moussaoui, Majdouline El, et al.
Publicado: (2022)

Serological response to vaccination in post-acute sequelae of COVID
por: Joung, Sandy, et al.
Publicado: (2023)

Single-Dose 13-Valent Conjugate Pneumococcal Vaccine in People Living With HIV – Immunological Response and Protection
por: Romaru, Juliette, et al.
Publicado: (2021)

Higher rate of long-term serologic response of four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: 4-year follow-up of a randomised controlled trial
por: Chaiwarith, Romanee, et al.
Publicado: (2019)

Serological Responses after a Fourth Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis
por: Mu, Yameng, et al.
Publicado: (2023)

The risk of rheumatoid arthritis among patients with inflammatory bowel disease: a systematic review and meta-analysis
por: Chen, Yi, et al.
Publicado: (2020)

Serological response to a single dose of a SARS-CoV-2 mRNA vaccine
por: Ramos, Angélica, et al.
Publicado: (2021)

Macrophage activation syndrome and pulmonary arterial hypertension in a patient with adult-onset Still disease: A case report
por: Zeng, Furong, et al.
Publicado: (2019)

Nomogram For Preoperative Prediction Of Microvascular Invasion Risk In Hepatocellular Carcinoma
por: Deng, Guangtong, et al.
Publicado: (2019)

Comparisons of Serologic Responses of Early Syphilis to Treatment with a Single-Dose Benzathine Penicillin G Between HIV-Positive and HIV-Negative Patients
por: Lin, Kuan-Yin, et al.
Publicado: (2021)

A novel predictive model incorporating immune-related gene signatures for overall survival in melanoma patients
por: Liao, Mengting, et al.
Publicado: (2020)

The Prognostic Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Melanoma Patients Receiving Immunotherapy
por: Li, Yayun, et al.
Publicado: (2022)

Neutralizing activity and T Cell response after bivalent fifth dose of mRNA vaccine in person living with HIV
por: Vergori, Alessandra, et al.
Publicado: (2023)

Serological response to 13-valent pneumococcal conjugate vaccine in children and adolescents with perinatally acquired HIV infection
por: Bamford, Alasdair, et al.
Publicado: (2014)

Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients
por: Osmanodja, Bilgin, et al.
Publicado: (2022)

Serological response to a third dose of SARS-CoV-2 vaccine according to previous infection history
por: Ota, Kenji, et al.
Publicado: (2023)

Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease
por: Quan, Joshua, et al.
Publicado: (2022)

Cytomegalovirus as an Uninvited Guest in the Response to Vaccines in People Living with HIV
por: Royston, Léna, et al.
Publicado: (2021)

Effect of cladribine on COVID-19 serology responses following two doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosis
por: Brill, Livnat, et al.
Publicado: (2022)

Immune Response to Hepatitis B Virus Vaccine Among People Living With HIV: A Meta-Analysis
por: Tian, Yakun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rp2715flpp554gefie9bolul4i